Trial Profile
A Phase 2, Open Label, Non-Comparative Trial Of Azithromycin 2000 mg Plus Chloroquine 600 Mg Base Daily For Three Days For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Jul 2014
Price :
$35
*
At a glance
- Drugs Chloroquine/azithromycin (Primary)
- Indications Falciparum malaria
- Focus Therapeutic Use
- Sponsors Pfizer
- 03 Jul 2014 New trial record